Loading
Dementia / Alzheimer Disease / Late Onset Alzheimer Disease · Observational Study
ClinicalTrials.gov · September 8, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is a clinical trial registry record describing an active observational genetics study, not a published results report. The study aims to collect biological specimens and genetic data from families with multiple members diagnosed with Alzheimer's disease or dementia to support future genetic research. No outcomes, effect sizes, or findings are reported in this registry entry.
Observational. Alzheimer Disease, Late Onset Alzheimer Disease, Dementia; age from 18 Years; accepts healthy volunteers. n = 10,000. 1 site: United States.
This is a clinical trial registry record describing an active observational genetics study, not a published results report. The study aims to collect biological specimens and genetic data from families with multiple members diagnosed with Alzheimer's disease or dementia to support future genetic research. No outcomes, effect sizes, or findings are reported in this registry entry.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
This is an active observational registry study with no posted results; it describes planned enrollment and specimen collection infrastructure rather than clinical outcomes or evidence.
As stated by the source record.
Quoted from the source exactly as published.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no key findings. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT00064870). This is a study registration, not published results. Lead sponsor: Indiana University. Recruitment status: RECRUITING. Study type: OBSERVATIONAL. Enrollment: 10000 participants (ESTIMATED). Conditions: Alzheimer Disease, Late Onset Alzheimer Disease, Dementia. Primary outcome measures: Distribute biological specimens to qualified investigators for use in their research studies. , Contact investigators annually for an update on progress and publication status.. Brief summary: The purpose of the Alzheimer's Disease Genetics Study is to identify the genes that are responsible for causing Alzheimer's Disease (AD). One of the ways in which the risk factor genes for late onset AD can be investigated is by identifying and collecting genetic material from families with multiple members diagnosed with AD or dementia.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.